BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19628258)

  • 1. Second primary cancer risk of radiation therapy after radical prostatectomy for prostate cancer: an analysis of SEER data.
    Abdel-Wahab M; Reis IM; Wu J; Duncan R
    Urology; 2009 Oct; 74(4):866-71. PubMed ID: 19628258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second primary cancer after radiotherapy for prostate cancer--a seer analysis of brachytherapy versus external beam radiotherapy.
    Abdel-Wahab M; Reis IM; Hamilton K
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):58-68. PubMed ID: 18374503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
    Nieder AM; Porter MP; Soloway MS
    J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer incidence after localized therapy for prostate cancer.
    Moon K; Stukenborg GJ; Keim J; Theodorescu D
    Cancer; 2006 Sep; 107(5):991-8. PubMed ID: 16878323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate brachytherapy and second primary cancer risk: a competitive risk analysis.
    Hinnen KA; Schaapveld M; van Vulpen M; Battermann JJ; van der Poel H; van Oort IM; van Roermund JG; Monninkhof EM
    J Clin Oncol; 2011 Dec; 29(34):4510-5. PubMed ID: 22025166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing age and treatment modality are predictors for subsequent diagnosis of bladder cancer following prostate cancer diagnosis.
    Singh AK; Mashtare TL; McCloskey SA; Seixas-Mikelus SA; Kim HL; May KS
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1086-94. PubMed ID: 20350797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of colorectal cancer and prostate cancer and impact of radiation therapy.
    Huo D; Hetzel JT; Roy H; Rubin DT
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):1979-85. PubMed ID: 19531678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients.
    Bhojani N; Capitanio U; Suardi N; Jeldres C; Isbarn H; Shariat SF; Graefen M; Arjane P; Duclos A; Lattouf JB; Saad F; Valiquette L; Montorsi F; Perrotte P; Karakiewicz PI
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):342-8. PubMed ID: 20117287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
    Liauw SL; Sylvester JE; Morris CG; Blasko JC; Grimm PD
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):669-73. PubMed ID: 16887293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE.
    Elliott SP; Meng MV; Elkin EP; McAninch JW; Duchane J; Carroll PR;
    J Urol; 2007 Aug; 178(2):529-34; discussion 534. PubMed ID: 17570425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of second malignancies after prostate irradiation?
    Müller AC; Ganswindt U; Bamberg M; Belka C
    Strahlenther Onkol; 2007 Nov; 183(11):605-9. PubMed ID: 17960335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of second primary cancer following prostate cancer radiotherapy: DVH analysis using the competitive risk model.
    Takam R; Bezak E; Yeoh EE
    Phys Med Biol; 2009 Feb; 54(3):611-25. PubMed ID: 19124952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to "The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients." (Int J Radiat Oncol Biol Phys 2010;76:342-348).
    Froehner M; Wirth MP
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1279; author reply 1280. PubMed ID: 20542389
    [No Abstract]   [Full Text] [Related]  

  • 14. Incidence of initial local therapy among men with lower-risk prostate cancer in the United States.
    Miller DC; Gruber SB; Hollenbeck BK; Montie JE; Wei JT
    J Natl Cancer Inst; 2006 Aug; 98(16):1134-41. PubMed ID: 16912266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary cancer and relapse rates following radical prostatectomy for prostate-confined cancer.
    Wesley D; Cox HF
    J Insur Med; 2007; 39(4):242-50. PubMed ID: 18522141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of second malignancies in prostate cancer patients treated with low-dose-rate brachytherapy and radical prostatectomy.
    Hamilton SN; Tyldesley S; Hamm J; Jiang WN; Keyes M; Pickles T; Lapointe V; Kahnamelli A; McKenzie M; Miller S; Morris WJ
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):934-41. PubMed ID: 25240272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer (Int J Radiat Oncol Biol Phys 2010;76:342-348).
    Hyde C
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1607; author reply 1607. PubMed ID: 20637987
    [No Abstract]   [Full Text] [Related]  

  • 18. Radiation therapy for prostate cancer increases the risk of subsequent rectal cancer.
    Margel D; Baniel J; Wasserberg N; Bar-Chana M; Yossepowitch O
    Ann Surg; 2011 Dec; 254(6):947-50. PubMed ID: 22107741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediagnosis smoking, obesity, insulin resistance, and second primary cancer risk in male cancer survivors: National Health Insurance Corporation Study.
    Park SM; Lim MK; Jung KW; Shin SA; Yoo KY; Yun YH; Huh BY
    J Clin Oncol; 2007 Oct; 25(30):4835-43. PubMed ID: 17947733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second cancers as competing causes of death after radical prostatectomy.
    Froehner M; Koch R; Hakenberg OW; Wirth MP
    J Urol; 2009 Sep; 182(3):967-70. PubMed ID: 19616262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.